Smead Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-259,009
Closed -$11.7M 31
2014
Q4
$11.7M Sell
259,009
-90,835
-26% -$3.96M 1.07% 28
2014
Q3
$14.6M Buy
349,844
+9,259
+3% +$392K 1.57% 27
2014
Q2
$13.9M Buy
340,585
+15,847
+5% +$622K 1.52% 26
2014
Q1
$12.5M Buy
324,738
+40,154
+14% +$1.55M 1.51% 26
2013
Q4
$10.9M Buy
284,584
+22,598
+9% +$833K 1.5% 26
2013
Q3
$8.7M Buy
261,986
+40,895
+18% +$1.43M 1.41% 27
2013
Q2
$7.71M Buy
+221,091
New +$8.11M 1.56% 27

Other funds holding ABT

Smead Capital Management's ABT Position: Q1 2015 in Review

Smead Capital Management sold out of Abbott (ABT) in Q1 2015, closing a stake of 259,009 shares — an estimated $11.7M sold.

Smead Capital Management first reported a position in ABT in Q2 2013 and held it in 7 quarters. The position peaked at $14.6M in Q3 2014. 1,474 funds tracked by Wall St. Rank hold ABT as of Q1 2015.

  • Smead Capital Management reported no remaining Abbott position as of Q1 2015 after selling out during the quarter.
  • Smead Capital Management sold 259,009 Abbott shares in Q1 2015, an estimated $11.7M.
  • Smead Capital Management first reported a position in Abbott in Q2 2013 and held it in 7 quarters.
  • Smead Capital Management's Abbott position peaked at $14.6M in Q3 2014.
  • 1,474 funds tracked by Wall St. Rank held Abbott as of Q1 2015.

Based on Smead Capital Management's 13F filing for Q1 2015, filed 8 May 2015.